The company says it is undervalued

Since August 24, the love of Ophthalmology (300015, close 17.26 yuan) share prices began to fall, starting from September 11 is "Seven consecutive Yin", yesterday the shares released a huge drop of 3.74%, creating a nearly two-year low. For the stock price plunge, there is analysis that the "knife incident" makes the company's para-molecular surgery is affected or one of the reasons; at the end of October, the release of 306 million of the first issue of restricted shares also brought great pressure on the company's share price. Affected by the February Taiwan eye doctor's "seal knife Incident", the growth of ophthalmic excimer surgery slowed, while the excimer surgery was the highest gross margin and net profit margin of all the company's operations. 2011, the company's quasi-molecular surgery accounted for 33.5%, gross margin accounted for 43.3%, the status of important. The negative effects of the "knife-cutting incident" are also reflected in the performance. In the first half of this year, AI Seoul's eye income grew 27.25% per cent year-on-year, but net profit growth was only 14.73%. In this respect, Zhong Ophthalmology director of the "Daily economic news" reporter said, "Knife incident" this bad already basically past, now the company is in the recovery phase. From the newspaper also can be seen, in addition to the impact of the excimer surgery, corporate cataract, fundus glaucoma treatment and mirror income growth is very good, "so we think the company's future development space is still very large, the company's fundamentals are no problem." In addition, the semi-annual newspaper showed that the company's first 306 million shares of restricted shares will be lifted on October 30, accounting for 71.66% of total equity. Including the holding shareholder Hunan AI ER Medical Investment Co., Ltd. 192 million shares, the actual control of Chen Bong 76.16 million, general manager Lili 22.912 million shares, deputy general manager Guo Hongwei 14.528 million shares. Because the cost of the original shareholders is very low, the lifting of the huge selling pressure caused the market concern. For the ban on restricted stocks, Zhong stressed that as the actual control of the majority of shareholders did not sell shares of the intention of the company's future is still full of confidence. The Chairman also believes that the current value is undervalued, so the market need not worry too much.